IP Library › Granted Patent US 10,413,666
Granted Patent B2
US 10,413,666 · App. 15/789,357 · Granted Sep 17, 2019

Hemoglobin display and patient treatment

Inventors: Ammar Al-Ali (San Juan Capistrano, CA); Massi Joe E. Kiani (Laguna Niguel, CA); Michael O'Reilly (Dana Point, CA)
Assignee: Masimo Corporation
A61M5/1723A61B5/1455A61B5/14546A61B5/14551A61B5/416A61B5/4836A61B5/6826A61B5/7257A61B5/742A61M1/024A61M1/1603A61B5/14532A61B5/14552A61M37/00A61M2230/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,413,666
App. No.
15/789,357
Filed
Oct 20, 2017
Granted
Sep 17, 2019
Kind
B2
Art Unit
2852
USPC
600/322
Abstract

The present disclosure describes embodiments of a patient monitoring system and methods that include the measure and display of hemoglobin statistics. In an embodiment, total hemoglobin trending is displayed over a period of time. Statistics can include frequency domain analysis, which may be unique for each patient monitored. The total hemoglobin trending and/or statistics can further be used to help control the treatment of a patient, such as being used to control IV administration.

Claims (25)

1. A transfusion system comprising:

a physiological monitor connected with a fluid delivery system;

a noninvasive sensor configured to emit energy into a measurement site of a patient and detect the energy attenuated by the patient measurement site; and

one or more hardware processors configured to:

determine a plurality of total hemoglobin measurements over a first time period based on the detected attenuated energy;

determine a trend in the plurality of total hemoglobin measurements over the first time period;

compare the trend with an expected limit of hemoglobin; and

control the fluid delivery system based on the determined trend and the comparison.

2. The transfusion system of claim 1 , wherein the trend is determined based on a frequency transformation of the plurality of total hemoglobin measurements over the first time period.

3. The transfusion system of claim 1 , wherein the physiological monitor comprises the one or more hardware processors.

4. The transfusion system of claim 1 , wherein the fluid delivery system comprises a tube, a fluid bag, and a needle configured for insertion into the patient.

5. The transfusion system of claim 4 , wherein the tube is directly connected to the physiological monitor.

6. The transfusion system of claim 4 , wherein the controlling of the fluid delivery system comprises controlling a rate or amount of fluid administered to the patient from the fluid bag.

7. The transfusion system of claim 1 , wherein the one or more hardware processors are further configured to stop fluid delivery from the fluid delivery system based on the comparison.

8. An electronic transfusion method comprising:

determining a plurality of total hemoglobin measurements over a first time period based on attenuated energy detected from a measurement site of a patient responsive to energy emitted by a noninvasive sensor into the measurement site;

determining a trend in the plurality of total hemoglobin measurements over the first time period;

comparing the trend with an expected limit of hemoglobin; and

controlling a fluid delivery system based on the determined trend and the comparison.

9. The electronic transfusion method of claim 8 , wherein the trend is determined based on a frequency transformation of the plurality of total hemoglobin measurements over the first time period.

10. The electronic transfusion method of claim 8 , wherein the electronic transfusion method is executed by the one or more hardware processors of a physiological monitor.

11. The electronic transfusion method of claim 8 , wherein the fluid delivery system comprises a tube, a fluid bad, and a needle configured for insertion into the patient.

12. The electronic transfusion method of claim 11 , wherein the tube is directly connected to a physiological monitor.

13. The electronic transfusion method of claim 11 , wherein the controlling of the fluid delivery system comprises controlling a rate or amount of fluid administered to the patient from the fluid bag.

14. The electronic transfusion method of claim 8 , wherein further comprising stopping fluid delivery from the fluid delivery system based on the comparison.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2024
From: AL-ALI, AMMAR; KIANI, MASSI JOE E.; O'REILLY, MICHAEL
To: MASIMO CORPORATION
Reel/Frame 068116/0266 →
Continuity (7)
Continuation 15184950 · Jun 16, 2016
Continuation 14714691 · May 18, 2015
Continuation 14064026 · Oct 25, 2013
Continuation 12783436 · May 19, 2010
Provisional Application 61221435 · Jun 29, 2009
Provisional Application 61180018 · May 20, 2009
Related Publication 20180161499A1 · Jun 14, 2018
Cited By (22)
US 1,132,251 US 12,193,813 US 12,193,849 US 12,205,208 US 12,211,617 US 12,230,396 US 12,232,905 US 12,238,489 US 12,257,022 US 12,302,426 US 12,318,175 US 12,318,229 US 12,402,843 US 12,440,171 US 12,484,844 US 12,495,968 US 12,514,503 US 12,521,039 US 12,592,009 US 12,611,117 US 12,648,718 US 12,733,847